NF-κB and androgen receptor variant expression correlate with human BPH progression

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

(2014) Z. Yu et al.   CLINICAL CANCER RESEARCH

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

(2014) Emmanuel S. Antonarakis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression

(2014) R Jin et al.   ONCOGENE

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network

(2014) Opal Lin-Tsai et al.   PROSTATE

Androgenic biomarker profiling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry

(2014) John H. Wilton et al.   PROSTATE

Hyperglycemia and Insulin Resistance and the Risk of BPH/LUTS: an Update of Recent Literature

(2014) Benjamin N. Breyer et al.   Current Urology Reports

Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues

(2014) Dong Gui Hu et al.   Hormones & Cancer

Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors

(2013) Feng Sun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NF- B2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

(2013) N. Nadiminty et al.   MOLECULAR CANCER THERAPEUTICS

Prostatic fibrosis, lower urinary tract symptoms and BPH

(2013) Jose A. Rodriguez-Nieves et al.   Nature Reviews Urology

Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

(2012) J. M. Schenk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Deficiency in Metabolic Regulators PPARγ and PTEN Cooperates to Drive Keratinizing Squamous Metaplasia in Novel Models of Human Tissue Regeneration

(2012) Douglas W. Strand et al.   AMERICAN JOURNAL OF PATHOLOGY

Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines

(2012) Y. Li et al.   CANCER RESEARCH

Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia

(2012) A A Madigan et al.   GENES AND IMMUNITY

Incidence and Progression of Lower Urinary Tract Symptoms in a Large Prospective Cohort of United States Men

(2012) Elizabeth A. Platz et al.   JOURNAL OF UROLOGY

PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation

(2012) D W Strand et al.   Cell Death & Disease

Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial

(2011) J. M. Schenk et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis

(2011) Omar E. Franco et al.   CANCER RESEARCH

α-Blockers for benign prostatic hyperplasia

(2011) Herbert Lepor et al.   CURRENT OPINION IN UROLOGY

Urological aspects of the metabolic syndrome

(2011) Jan Hammarsten et al.   Nature Reviews Urology

Estrogen and androgen signaling in the pathogenesis of BPH

(2011) Clement K. M. Ho et al.   Nature Reviews Urology

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases

(2011) Xiaotun Zhang et al.   PLoS One

A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities

(2011) Rong Hu et al.   PROSTATE

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

(2010) Shihua Sun et al.   JOURNAL OF CLINICAL INVESTIGATION

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

(2010) P. A. Watson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

(2009) Liying Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth

(2009) Z. Guo et al.   CANCER RESEARCH

 1-Adrenergic Receptor Stimulates Interleukin-6 Expression and Secretion through Both mRNA Stability and Transcriptional Regulation: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor- B

(2009) D. M. Perez et al.   MOLECULAR PHARMACOLOGY

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

(2008) S. M. Dehm et al.   CANCER RESEARCH

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

(2008) R. Hu et al.   CANCER RESEARCH

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

(2007) J. Curtis Nickel et al.   EUROPEAN UROLOGY

NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2

(2007) Philip Diessenbacher et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY